365 related articles for article (PubMed ID: 34607452)
21. Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal Antibody.
Yue S; Li Z; Lin Y; Yang Y; Yuan M; Pan Z; Hu L; Gao L; Zhou J; Tang J; Wang Y; Tian Q; Hao Y; Wang J; Huang Q; Xu L; Zhu B; Liu P; Deng K; Wang L; Ye L; Chen X
Front Immunol; 2021; 12():751584. PubMed ID: 34630430
[TBL] [Abstract][Full Text] [Related]
22. Temporal-Geographical Dispersion of SARS-CoV-2 Spike Glycoprotein Variant Lineages and Their Functional Prediction Using
Boon SS; Xia C; Wang MH; Yip KL; Luk HY; Li S; Ng RWY; Lai CKC; Chan PKS; Chen Z
mBio; 2021 Oct; 12(5):e0268721. PubMed ID: 34700382
[TBL] [Abstract][Full Text] [Related]
23. SARS-CoV-2 spike protein receptor-binding domain N-glycans facilitate viral internalization in respiratory epithelial cells.
Zheng L; Ma Y; Chen M; Wu G; Yan C; Zhang XE
Biochem Biophys Res Commun; 2021 Nov; 579():69-75. PubMed ID: 34592572
[TBL] [Abstract][Full Text] [Related]
24. Characterization of SARS-CoV-2 Escape Mutants to a Pair of Neutralizing Antibodies Targeting the RBD and the NTD.
Peter AS; Grüner E; Socher E; Fraedrich K; Richel E; Mueller-Schmucker S; Cordsmeier A; Ensser A; Sticht H; Überla K
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897753
[TBL] [Abstract][Full Text] [Related]
25. Recognition through GRP78 is enhanced in the UK, South African, and Brazilian variants of SARS-CoV-2; An in silico perspective.
Ibrahim IM; Elfiky AA; Elgohary AM
Biochem Biophys Res Commun; 2021 Jul; 562():89-93. PubMed ID: 34049205
[TBL] [Abstract][Full Text] [Related]
26. Will Mutations in the Spike Protein of SARS-CoV-2 Lead to the Failure of COVID-19 Vaccines?
Jia Z; Gong W
J Korean Med Sci; 2021 May; 36(18):e124. PubMed ID: 33975397
[TBL] [Abstract][Full Text] [Related]
27. A Barcoded Flow Cytometric Assay to Explore the Antibody Responses Against SARS-CoV-2 Spike and Its Variants.
Vesper N; Ortiz Y; Bartels-Burgahn F; Yang J; de la Rosa K; Tenbusch M; Schulz S; Finzel S; Jäck HM; Eibel H; Voll RE; Reth M
Front Immunol; 2021; 12():730766. PubMed ID: 34630410
[TBL] [Abstract][Full Text] [Related]
28. Aggregation of high-frequency RBD mutations of SARS-CoV-2 with three VOCs did not cause significant antigenic drift.
Li T; Cui Z; Jia Y; Liang Z; Nie J; Zhang L; Wang M; Li Q; Wu J; Xu N; Liu S; Li X; An Y; Han P; Zhang M; Li Y; Qu X; Wang Q; Huang W; Wang Y
J Med Virol; 2022 May; 94(5):2108-2125. PubMed ID: 35032057
[TBL] [Abstract][Full Text] [Related]
29. Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine.
Melo-González F; Soto JA; González LA; Fernández J; Duarte LF; Schultz BM; Gálvez NMS; Pacheco GA; Ríos M; Vázquez Y; Rivera-Pérez D; Moreno-Tapia D; Iturriaga C; Vallejos OP; Berríos-Rojas RV; Hoppe-Elsholz G; Urzúa M; Bruneau N; Fasce RA; Mora J; Grifoni A; Sette A; Weiskopf D; Zeng G; Meng W; González-Aramundiz JV; González PA; Abarca K; Ramírez E; Kalergis AM; Bueno SM
Front Immunol; 2021; 12():747830. PubMed ID: 34858404
[TBL] [Abstract][Full Text] [Related]
30. Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization.
Zhang L; Cui Z; Li Q; Wang B; Yu Y; Wu J; Nie J; Ding R; Wang H; Zhang Y; Liu S; Chen Z; He Y; Su X; Xu W; Huang W; Wang Y
Commun Biol; 2021 Oct; 4(1):1196. PubMed ID: 34645933
[TBL] [Abstract][Full Text] [Related]
31. A comprehensive overview of identified mutations in SARS CoV-2 spike glycoprotein among Iranian patients.
Eslami S; Glassy MC; Ghafouri-Fard S
Gene; 2022 Mar; 813():146113. PubMed ID: 34896524
[TBL] [Abstract][Full Text] [Related]
32. SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape.
Li Q; Nie J; Wu J; Zhang L; Ding R; Wang H; Zhang Y; Li T; Liu S; Zhang M; Zhao C; Liu H; Nie L; Qin H; Wang M; Lu Q; Li X; Liu J; Liang H; Shi Y; Shen Y; Xie L; Zhang L; Qu X; Xu W; Huang W; Wang Y
Cell; 2021 Apr; 184(9):2362-2371.e9. PubMed ID: 33735608
[TBL] [Abstract][Full Text] [Related]
33. A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy.
Greaney AJ; Starr TN; Eguia RT; Loes AN; Khan K; Karim F; Cele S; Bowen JE; Logue JK; Corti D; Veesler D; Chu HY; Sigal A; Bloom JD
PLoS Pathog; 2022 Feb; 18(2):e1010248. PubMed ID: 35134084
[TBL] [Abstract][Full Text] [Related]
34. Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variants.
Li K; Huntwork RHC; Horn GQ; Abraha M; Hastie KM; Li H; Rayaprolu V; Olmedillas E; Feeney E; Cronin K; Schendel SL; Heise M; Bedinger D; Mattocks MD; Baric RS; Alam SM; Ollmann Saphire E; Tomaras GD; Dennison SM
J Virol; 2023 Dec; 97(12):e0107023. PubMed ID: 38019013
[TBL] [Abstract][Full Text] [Related]
35. Genomic Epidemiology and Serology Associated with a SARS-CoV-2 R.1 Variant Outbreak in New Jersey.
Mathema B; Chen L; Wang P; Cunningham MH; Mediavilla JR; Chow KF; Luo Y; Zhao Y; Composto K; Zuckerman J; Zody MC; Wilson N; Lee A; Oschwald DM; Liu L; Iketani S; Germer S; Fennessey S; Wang M; Kramer Y; Toole P; Maniatis T; Ho DD; Perlin DS; Kreiswirth BN
mBio; 2022 Oct; 13(5):e0214122. PubMed ID: 35997285
[TBL] [Abstract][Full Text] [Related]
36. Equine Anti-SARS-CoV-2 Serum (ECIG) Binds to Mutated RBDs and N Proteins of Variants of Concern and Inhibits the Binding of RBDs to ACE-2 Receptor.
Andrade SA; Batalha-Carvalho JV; Curi R; Wen FH; Covas DT; Chudzinski-Tavassi AM; Moro AM
Front Immunol; 2022; 13():871874. PubMed ID: 35898497
[TBL] [Abstract][Full Text] [Related]
37. SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma.
Andreano E; Piccini G; Licastro D; Casalino L; Johnson NV; Paciello I; Dal Monego S; Pantano E; Manganaro N; Manenti A; Manna R; Casa E; Hyseni I; Benincasa L; Montomoli E; Amaro RE; McLellan JS; Rappuoli R
Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34417349
[TBL] [Abstract][Full Text] [Related]
38. Epitope Profiling Reveals the Critical Antigenic Determinants in SARS-CoV-2 RBD-Based Antigen.
Jiang M; Zhang G; Liu H; Ding P; Liu Y; Tian Y; Wang Y; Wang A
Front Immunol; 2021; 12():707977. PubMed ID: 34621266
[TBL] [Abstract][Full Text] [Related]
39. Neutralizing antibodies targeting the SARS-CoV-2 receptor binding domain isolated from a naïve human antibody library.
Bell BN; Powell AE; Rodriguez C; Cochran JR; Kim PS
Protein Sci; 2021 Apr; 30(4):716-727. PubMed ID: 33586288
[TBL] [Abstract][Full Text] [Related]
40. Rapid screening for SARS-CoV-2 variants of concern in clinical and environmental samples using nested RT-PCR assays targeting key mutations of the spike protein.
La Rosa G; Mancini P; Bonanno Ferraro G; Veneri C; Iaconelli M; Lucentini L; Bonadonna L; Brusaferro S; Brandtner D; Fasanella A; Pace L; Parisi A; Galante D; Suffredini E
Water Res; 2021 Jun; 197():117104. PubMed ID: 33857895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
